Etoposide and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Etoposide (etoposide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Carboplatin, and have Lung cancer - small cell.

The phase IV clinical study analyzes which people have Uveitis when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,529 conditions by eHealthMe. Check the latest studies of Uveitis.

On Jul, 22, 2026

77,756 people reported to have side effects when taking Etoposide.
Among them, 16 people (0.02%) have Uveitis.

Among these 16 people:

How long have people been on Etoposide when they have Uveitis? *

What is the gender of people who have Uveitis when taking Etoposide? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Uveitis when taking Etoposide? *

What are other drugs people take besides Etoposide? *

What are other side effects people have besides Uveitis? *

Meningitis Aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed): 6 people, 37.50%
Eye Infection Toxoplasmal (a germ called toxoplasma can cause infection within the eye): 3 people, 18.75%
Weakness: 2 people, 12.50%
Blindness: 2 people, 12.50%
Dehydration (dryness resulting from the removal of water): 2 people, 12.50%
Gastrointestinal Toxicity (damage to digestive tract by any substance): 2 people, 12.50%
Herpes Zoster: 2 people, 12.50%
Intervertebral Disc Degeneration (spinal disc degeneration): 1 person, 6.25%
Anaemia (lack of blood): 1 person, 6.25%
Cardiomyopathy (weakening of the heart muscle): 1 person, 6.25%

What are the existing conditions these people have? *

Lung Cancer - Small Cell (lung cancer): 7 people, 43.75%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 18.75%
T-Cell Lymphoma (a blood cell cancer): 1 person, 6.25%
Myasthenia Gravis Crisis (a paralysis of the respiratory muscles occurs): 1 person, 6.25%
Lymphoma (cancer that begins in immune system cells): 1 person, 6.25%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 1 person, 6.25%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 6.25%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 1 person, 6.25%
B-Cell Lymphoma Stage Iii (blood cancer affecting b cells stage iii): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etoposide:

Etoposide (77,815 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,529 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.